TEST TUBE, BLOOD COL

The contract specifies the procurement of 7 mL vacuum blood collection tubes with sodium fluoride additive, identified by NSN 6640001451534 and part numbers from approved manufacturers including Baxter Healthcare Corp and Cardinal Health. Each unit is packaged in batches of 100 per package and must maintain a shelf life of 45 months, with no more than eight months elapsed from the date of manufacture to delivery. The tubes are regulated by the FDA, requiring referral for confirmation prior to award. Packaging must comply with DLA's Medical Marking Standard No. 1, which supersedes MIL-STD-129, and include mandatory labeling with NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and contract or lot number. All units must be sealed in protective containers and shipped in commercial exterior packaging compliant with ASTM D3951 unless deemed hazardous, in which case IP025 requirements apply. Palletization and handling follow DLA Packaging Requirements for Procurement (RP001), and shipment must occur via the fastest traceable means—parcel post is prohibited. Deliveries are required at three distinct locations, including San Antonio, Texas, and Kunsan Air Base in South Korea, with delivery windows between June and July 2026, all on a FOB destination basis with zero tolerance for quantity variance. The contract is governed by the DLA Master List of Technical and Quality Requirements, which override any conflicting standards, and all documentation must align with DoD authorized units of issue.